OVID Research Revenue and Competitors
Estimated Revenue & Valuation
- OVID Research's estimated annual revenue is currently $4.5M per year.
- OVID Research's estimated revenue per employee is $155,000
Employee Data
- OVID Research has 29 Employees.
OVID Research's People
| Name | Title | Email/Phone |
|---|
OVID Research Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is OVID Research?
Working on generating viable eggs from stem cells
keywords:N/A
N/A
Total Funding
29
Number of Employees
$4.5M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
OVID Research News
2022-04-19 - Long Covid Is Americas Forgotten Pandemic Problem
Senator Tim Kaine, who has symptoms of long Covid, introduced legislation in March to expand research and provide resources for medical...
2022-04-13 - Ovid Adds Support for Clinician Performance Improvement and Patient-Centered Communication With Astute Doctor
WALTHAM, Mass., April 13, 2022--(BUSINESS WIRE)--Wolters Kluwer, Health announced that its medical research platform, Ovid®,...
2022-04-06 - Ovid Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. ... For more information about these and other Ovid research programs,...
Other Companies in Berkeley
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.8M | 29 | N/A | N/A |
#2 | $5.9M | 29 | 0% | N/A |
#3 | $4.5M | 29 | -12% | N/A |
#4 | $3.7M | 29 | 16% | N/A |
#5 | $2.9M | 29 | -3% | N/A |